| scholarly article | Q13442814 |
| P2093 | author name string | Jones KL | |
| Glaser NS | |||
| P2860 | cites work | Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) | Q28298538 |
| Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota | Q34057383 | ||
| Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus | Q34061740 | ||
| Maturity-onset diabetes of youth in black Americans | Q34183134 | ||
| The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. | Q34656644 | ||
| Excess Insulin Binding to Insulin-Like Growth Factor Receptors: Proposed Mechanism for Acanthosis Nigricans | Q35228331 | ||
| Maturity Onset-type Diabetes of the Young (MODY): One Condition or Many? | Q37096429 | ||
| Insulin resistance--mechanisms, syndromes, and implications | Q37278330 | ||
| Scope and heterogeneous nature of MODY. | Q38139081 | ||
| Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess | Q38351252 | ||
| Racial differences in incidence of juvenile-onset type 1 diabetes: epidemiologic studies in southern California | Q39863588 | ||
| Insulin secretion in diabetes mellitus | Q40302183 | ||
| Can we really predict IDDM? | Q40871649 | ||
| Five-year follow-up of islet cell antibodies in type 2 (non-insulin-dependent) diabetes mellitus | Q41150413 | ||
| C-Peptide and Insulin Secretion in Pima Indians and Caucasians: Constant Fractional Hepatic Extraction over a Wide Range of Insulin Concentrations and in Obesity* | Q41500317 | ||
| HLA heterogeneity of insulin-dependent diabetes mellitus at diagnosis. The Pittsburgh IDDM study | Q43989831 | ||
| Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables | Q44594587 | ||
| C-peptide measurement in the differentiation of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus | Q44839344 | ||
| C-peptide in NIDDM. Follow-up for 4-6 yr. | Q46257000 | ||
| Epidemiological correlates of NIDDM in Hispanics, whites, and blacks in the U.S. population | Q46547840 | ||
| Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial | Q46936072 | ||
| Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) | Q48056898 | ||
| Clinical and laboratory features of type 1 diabetic children at the time of diagnosis. | Q50543768 | ||
| A nationwide population-based study of the familial aggregation of type 1 (insulin-dependent) diabetes mellitus in Denmark. Danish Study Group of Diabetes in Childhood. | Q50558674 | ||
| Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. | Q51033548 | ||
| Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. | Q51604603 | ||
| Insulin resistance and acanthosis nigricans: evidence for a postbinding defect in vivo. | Q51614073 | ||
| Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents. | Q51620522 | ||
| Human C-peptide in normal and diabetic subjects | Q51673334 | ||
| Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. | Q54218029 | ||
| Familial insulin resistance with acanthosis nigricans, acral hypertrophy, and muscle cramps. | Q54546779 | ||
| Analysis of diabetic family connection in subjects with insulin-dependent diabetes mellitus (IDDM) | Q58829539 | ||
| Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children | Q61861661 | ||
| Types of diabetes according to National Diabetes. Data Group Classification. Limited applicability and need to revisit | Q68396882 | ||
| Increased incidence of type II diabetes mellitus in Mexican Americans | Q70212744 | ||
| Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults | Q70381448 | ||
| Prevalence of diabetes in Mexican Americans. Relationship to percent of gene pool derived from native American sources | Q71251173 | ||
| Characterization of insulin receptors in patients with the syndromes of insulin resistance and acanthosis nigricans | Q72132797 | ||
| NIDDM in Mexican-American families. Heterogeneity by age of onset | Q72179934 | ||
| Maternal effect and familial aggregation in NIDDM. The CODIAB Study. CODIAB-INSERM-ZENECA Study Group | Q72659757 | ||
| Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients | Q93728462 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 11-16 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Western Journal of Medicine | Q7476269 |
| P1476 | title | Non-insulin dependent diabetes mellitus in Mexican-American children | |
| P478 | volume | 168 |
| Q30343781 | Are household factors putting immigrant Hispanic children at risk of becoming overweight: a community-based study in eastern North Carolina. |
| Q33890658 | Cardiovascular risk factors in Chinese American children: associations between overweight, acculturation, and physical activity |
| Q35279474 | Developing multi-faith chaplaincy. |
| Q36324354 | Hyperglycemic comas in children: new insights into pathophysiology and management |
| Q51772326 | The changing spectrum of diabetes in Mexican American youth. |
| Q35078474 | Type 2 diabetes in children and youth |
| Q35134259 | Type 2 diabetes mellitus in adolescence: lipid and cardiovascular risk factors |
| Q35279725 | Understanding the rising incidence of type 2 diabetes in adolescence |
Search more.